Replies to post #484795 on NorthWest Biotherapeutics Inc (NWBO)

[pgsd]

Excellent post, thanks for sharing :-

[Chiugray]

Excellent post.

[extrooper]

Great summary of how company is definitely up to the task.

[Mionaer1]

Great post. Thank you!

[eagle8]

Great post TDD.
Thanks a lot !

GLTU

[biosectinvestor]

Thanks TDD, an excellent and thorough post!

[dmb2]

TDD, thx, a tiny company like NWBO cannot be all things to all people, at least not yet, good big picture summary!

GLTA, much more coming here

[ison929]

Superbly illustrated. Thanks
NWBO is almost there and be rewarded.

ison929.

[MI Dendream]

Well done Swegen!

[hoffmann6383]

nice work tdd!

[JohnnyMacJohnJohn]

Thanks for helping me to see things clearly. Sometimes I get impatient and forget just how busy they have been.

[reachjo]

Better than morning coffee! Thank DD!

[ATLnsider]

Thank you for sharing a very nice recap Danish Dude

[KevGee59]

Another Brilliant Post!!

[Troymister]

Well done, Danish Dude!

[Nix59]

Hey DD, fine points but they didn’t even HAVE a tote bag this ASCO. So, not up to task it is! Sorry to disagree with such force.

[danielboog2]

No one knows at this point, if approval at RAs has already been seeked

Do those include Linda!

Thanks for proving my point. Pathetic after 2015 much of the info known to shareholders has been acquired by astute shareholders "scrounging the bushes" for tidbits of incomplete info and knowledge to piece together an incomplete projection. It's not the way info and shareholders should collude. The Quiet Period began in 2014/2015, not in 10/2020.

PRIORITY NO.1 .....FDA DC VAX L APPROVAL
After 3 years of having trial data info to begin processing where's the BLA? At the minimum we're looking at another 2 years but likely 4 or 5 years until approval.

Thanks for sharing your composed probables of apparent events.

[Poor Man -]

The good news is that progress has been made with the sharing of trial results, so the biggest risk has been taken off the table. Sigh of relief.

However, the lack of communication and the guess work for overall progress has left many shareholders aghast. Really, what are they doing!?

I will say this again. The publication at this stage should not be what all other decisions should be orbiting. They have to move forward as if the publication doesn’t exist. And when it shows up, great, icing on the cake.